Search | JOV | ARVO Journals

jov

Issues
Topics
For Authors
About
- Editorial Board

Journals Home

MANAGE ALERTS

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board

Narrow View

NARROW

Content Type

Meeting Abstract (63)
Journal Articles (6)

Journal

Investigative Ophthalmology & Visual Science (64)
Journal of Vision (4)
Translational Vision Science & Technology (1)

Article Type

ARVO Annual Meeting Abstract (61)
Article (2)
Retinal Cell Biology (2)
Vision Sciences Society Annual Meeting Abstract (2)
Letters to the Editor (1)
Translational (1)

Topics

Eye Anatomy and Disorders (4)
Retina (4)
Immunology and Microbiology (2)
Translational Research (2)
Genetics (1)
Pharmacology (1)
Retinal Cell Biology (1)
Spatial Vision (1)
Visual Psychophysics and Physiological Optics (1)

Tags

harmonics (2)
retinal cone (2)
waveforms (2)
aflibercept (1)
angiopoietins (1)
contrast sensitivity (1)
embryo (1)
flow cytometry (1)
krypton (1)
mitf protein (1)

Specify Date Range

From: To: Apply

Showing 1 – 20 of 69

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Creation of a Collagen Producing Cell Atlas in a Model of Sub-Retinal Fibrosis

Sarah Doyle; Ema Ozaki; Said Aktas; Peter D Westenskow; Derrick Feenstra

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):766.

ARVO Annual Meeting Abstract June 2024

Defining the Role of Angiopoietin-2 in Vascular Destabilization Using Primary Human Vasculature Models

Peter D Westenskow; Roland Stoll; Alena Spielmann; Bo Kyoung Kim; Heloise Ragelle

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):266.

Letters to the Editor October 2023

Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME

PDF

Robert L. Avery; Karl G. Csaky; Peter Westenskow; Ivaylo Stoilov; Cheikh Diack
TAGS: aflibercept, angiopoietins
Trans. Vis. Sci. Tech.. 2023; 12(10):6. https://doi.org/10.1167/tvst.12.10.6

ARVO Annual Meeting Abstract June 2023

Fibrosis prevention in nAMD: identification of subretinal fibrosis triggers and inhibitors using improved tools

Peter D Westenskow; Ema Ozaki; Sarah Doyle; Christophe Roubeix

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2116.

ARVO Annual Meeting Abstract June 2023

Multi-level characterization of the hypoxic stress response in retinal pigment epithelial cells

Lisa Grönnert; Juliane Siebourg-Polster; Florian Peters; Desiree von Tell; David Avila; Roland Schmucki; Megana Prasad; Manuel Tzouros; Javier Gayan; Peter D Westenskow

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2968.

ARVO Annual Meeting Abstract June 2023

Histopathological characterization of connective tissue growth factor (CTGF) expression in human eyes with age-related macular degeneration and diabetic retinopathy

Ella Arnon; Mathieu Brecheisen; Sabine Uhles; Peter D Westenskow; Eleonora M Lad; Alan D. Proia

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2749.

ARVO Annual Meeting Abstract June 2022

Optn can protect Ripk1-dependent cell death in the retina by selective autophagy.

Bo Kyoung Kim; Peter Westenskow; Domagoj Vucic; Filip Roudnicky

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1591 – A0380.

ARVO Annual Meeting Abstract June 2022

The Role of the STING/Type I IFN Signaling Pathway in Diabetic Retinopathy

Haitao Liu; Anastasiia Strizhakova; Stacey L Hose; Chao Huang; Pamela Strassburger; Gabriella Widmer; Alan D Proia; Eleonora Lad; Peter Westenskow; Nikolaos Mitrousis; Derrick Feenstra; Debasish Sinha

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):413.

ARVO Annual Meeting Abstract June 2022

Characterizing cellular senescence to prevent retinal ganglion cell loss in glaucoma

Chris Louche; Praveena Manogaran; Nadine Colé; Peter Westenskow; Joana Galvao

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):930 – A0399.

ARVO Annual Meeting Abstract June 2022

Angiopoietin-2 (Ang-2) signaling and vascular stability with faricimab in diabetic macular edema (DME)

Yasha Modi; Karl Csaky; Veeral Sheth; Jeffrey Willis; Zdenka Haskova; Peter Westenskow

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2522 – F0248.

ARVO Annual Meeting Abstract June 2022

Collagen dynamics in one-stage versus two-stage laser-induced choroidal neovascularization using Collagen-1-YFP reporter mice

Ema Ozaki; Peter Westenskow; Derrick Feenstra; Sarah L Doyle

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3871.

ARVO Annual Meeting Abstract June 2022

Use of collagen-hybridizing peptides to assess active fibrosis in 2 mouse models of choroidal neovascularization

Peter Westenskow; Lucas Bennink; Richard Foxton; Mike Kirkness; Markus Linder

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3870.

ARVO Annual Meeting Abstract June 2022

Selective Vulnerability of the Intermediate Retinal Capillary Plexus Precedes RGC Loss in Experimental Glaucoma.

Priyamvada M Pitale; Guofu Shen; Rohini Sigireddi; Maria Polo Prieto; Yong H Park; Peter Westenskow; Roomasa Channa; Benjamin J Frankfort

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4036 – A0421.

ARVO Annual Meeting Abstract June 2022

The Role of the STING/Type I IFN Signaling Pathway in Age-Related Macular Degeneration(AMD)

Chao Huang; Gabriella Widmer; Pamela Strassburger; Mirjana Lazendic; Sabine Gruener; Haitao Liu; Alan Proia; Eleonora Lad; Peter Westenskow; Nikolaos Mitrousis; Debasish Sinha; Derrick Feenstra

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4598 – F0390.

ARVO Annual Meeting Abstract June 2021

Simultaneous Ang-2/VEGF-A inhibition prevents subretinal fibrosis progression in preclinical mouse models of choroidal neovascularization (CNV)

Markus Linder; Richard Foxton; Sabine Uhles; Franco Revelant; Mirjana Lazendic; Jérémie Canonica; Marina Garcia Garrido; Peter Westenskow

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):349.

ARVO Annual Meeting Abstract June 2021

VEGF-A/Ang-2 neutralization causes sustained prevention of subretinal macrophage infiltration in a mouse model of spontaneous choroidal neovascularization

Jérémie Canonica; Sabine Uhles; Richard Foxton; Nadine Cole; Mirjana Lazendic; Marina Garcia Garrido; Peter Westenskow

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):274.

ARVO Annual Meeting Abstract June 2021

Multi-omics based metabolic profiling of the retinal pigment epithelium

Lisa Grönnert; David Avila; Juliane Siebourg-Polster; Fabian Köchl; Manuel Tzouros; Megana Prasad; Javier Gayan; Peter Westenskow

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2229.

ARVO Annual Meeting Abstract June 2020

Inflammatory cytokine analysis of ocular fluids from a primate model of chronic vascular leakage and neovascularization

Chintan Patel; Donnicia James; Wenzheng Hu; Robin J Goody; Rahel Zulliger; Gabriella Widmer; Peter D Westenskow; Matthew S Lawrence

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5395.

ARVO Annual Meeting Abstract July 2019

Screening stem cell-derived Claudin5-GFP engineered endothelial cells for novel compounds that regulate vascular permeability and characterizing their effects in vitro and in vivo.

Peter D Westenskow; Sabine Gruener; Franco Relevant; Sabine Uhles; Mirjana Lazendic; Filip Roudnicky

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1638.

ARVO Annual Meeting Abstract July 2018

Preclinical Animal Safety Study with CR4-RPE Cells

John Mazzilli; Joshua Snook; Ken Simmons; Aleksey Domozhirov; Charles A Garcia; Rick Wetsel; Eva Zsigmond; Peter Westenskow

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2446.

« Previous

1 2 3 4

Next 20 Results »

Advertisement

Follow @ARVOjov

JOV Home
Issues
Topics
For Authors

About
- Editorial Board

Online ISSN: 1534-7362

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2024 Association for Research in Vision and Ophthalmology.

Access Provided By:
MIT Libraries

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept